Page last updated: 2024-10-25

cimetidine and Pachymeningitis

cimetidine has been researched along with Pachymeningitis in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research Excerpts

ExcerptRelevanceReference
"Neurocysticercosis is the most important parasitic infection of the nervous system in countries of the third world."2.38Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy. ( Overbosch, D, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Overbosch, D1

Reviews

1 review available for cimetidine and Pachymeningitis

ArticleYear
Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy.
    Schweizerische medizinische Wochenschrift, 1992, Jun-06, Volume: 122, Issue:23

    Topics: Albendazole; Central Nervous System Diseases; Cimetidine; Cysticercosis; Diagnosis, Differential; Di

1992